Evidence map›Paper›PMID 40317832›Full record

ArticleHuman brain mapping2025

Mapping Brain Lesions to Conduction Delays: The Next Step for Personalized Brain Models in Multiple Sclerosis.

C Mazzara, A Ziaeemehr, E Troisi Lopez, L Cipriano, M Angiolelli, M Sparaco, M Quarantelli, C Granata, G Sorrentino, M Hashemi and 2 more

Abstract read
In one paragraph

Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The neurotoxic legacy of CAR-T cells: where do we stand?Therapeutic advances in neurological disorders · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

C MazzaraDepartment of Promoting Health, Maternal-Infant. Excellence and Internal and Specialized Medicine (PROMISE) G. D'alessandro, University of Palermo, Palermo, Italy.ORCID 0000-0002-1630-7803
A ZiaeemehrInst Neurosci Syst, Aix Marseille Univ, INSERM, INS, Marseille, France.
E Troisi LopezNational Research Council, Institute of Applied Sciences and Intelligent Systems, Pozzuoli, Italy.ORCID 0000-0002-0220-2672
L CiprianoDepartment of Medical Motor and Wellness Sciences, University of Naples "Parthenope", Naples, Italy.ORCID 0000-0002-5651-4970
M AngiolelliInst Neurosci Syst, Aix Marseille Univ, INSERM, INS, Marseille, France.
M SparacoDepartment of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy.
M QuarantelliBiostructure and Bioimaging Institute, National Research Council, Naples, Italy.
C GranataNational Research Council, Institute of Applied Sciences and Intelligent Systems, Pozzuoli, Italy.
G SorrentinoNational Research Council, Institute of Applied Sciences and Intelligent Systems, Pozzuoli, Italy.
M HashemiInst Neurosci Syst, Aix Marseille Univ, INSERM, INS, Marseille, France.
V JirsaInst Neurosci Syst, Aix Marseille Univ, INSERM, INS, Marseille, France.
P SorrentinoInst Neurosci Syst, Aix Marseille Univ, INSERM, INS, Marseille, France.ORCID 0000-0002-9556-9800

Funding

EBRAINS 2.0 Project 101147319European Union's Horizon 2020Italian National Recovery and Resilience Plan (NRRP), M4C2, funded by the European Union - NextGenerationEU (IR0000011, CUP B51E22000150006, EBRAINS-Italy) CUP B51E22000150006Italian National Recovery and Resilience Plan (NRRP), M4C2, funded by the European Union - NextGenerationEU (IR0000011, CUP B51E22000150006, EBRAINS-Italy) IR0000011Virtual Brain Twin Project 101137289
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a clinically heterogeneous, multifactorial autoimmune disorder affecting the central nervous system. Structural damage to the myelin sheath, resulting in the consequent slowing of the conduction velocities, is a key pathophysiological mechanism. In fact, the conduction velocities are closely related to the degree of myelination, with thicker myelin sheaths associated to higher conduction velocities. However, how the intensity of the structural lesions of the myelin translates to slowing of nerve conduction delays is not known. In this work, we use large-scale brain models and Bayesian model inversion to estimate how myelin lesions translate to longer conduction delays across the damaged tracts. A cohort of 38 subjects (20 healthy and 18 with MS) underwent MEG recordings during an eyes-closed resting-state condition, along with MRI acquisitions and detailed white matter tractography analysis. We observed that MS patients consistently showed decreased power within the alpha frequency band (8-13 Hz) as compared to the healthy group. We also derived a lesion matrix indicating the percentage of lesions for each tract in every patient. Using large-scale brain modeling, the neural activity of each region was represented as a Stuart-Landau oscillator operating in a regime showing damped oscillations, and the regions were coupled according to subject-specific connectomes. We propose a linear formulation to the relationship between the conduction delays and the amount of structural damage in each white matter tract. Dependent upon the parameter

Indexed as

BrainModels, NeurologicalMultiple SclerosisNeural ConductionWhite MatterAdultBayes TheoremDiffusion Tensor ImagingFemaleHumansMagnetic Resonance ImagingMagnetoencephalographyMaleMiddle AgedMyelin SheathBayesian inferenceconduction delaysmagnetoencephalographymultiple sclerosispersonalized brain models

Identifiers

PMID40317832
PMCPMC12048862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.